Skip to content

Clinical trials

Thrombocythemia, Essential trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Country / region: Netherlands Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20132
20142
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CTI BioPharma2
Constellation Pharmaceuticals1
Copenhagen University Hospital at Herlev1
European Organisation for Research and Treatment of Cancer - EORTC1
Incyte Corporation1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Shire1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential9
Hematologic Diseases5
Polycythemia Vera5
Primary Myelofibrosis5
Bone Marrow Diseases4
Myeloproliferative Disorders4
Anemia2
Hemorrhagic Disorders2
Leukemia, Myeloid, Acute2
Neoplasms2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.